Ordinary shares of Kura Oncology, Inc., trading on the NASDAQ exchange under the ticker symbol KURA, maintain a market valuation hovering around $13.59 per share. Public equity valuations adjust dynamically throughout active trading sessions in response to daily market liquidity, institutional order matching, clinical trial announcements, and periodic financial disclosures. Market participants tracking the security should consult live financial market data platforms or brokerage accounts for exact up-to-the-minute pricing information.